Kuiper, Rowan
Wright, Victoria J.
Habgood-Coote, Dominic
Shimizu, Chisato
Huigh, Daphne
Tremoulet, Adriana H.
van Keulen, Danielle
Hoggart, Clive J.
Rodriguez-Manzano, Jesus
Herberg, Jethro A.
Kaforou, Myrsini
Tempel, Dennie
Burns, Jane C.
Levin, Michael
Article History
Received: 3 February 2022
Revised: 18 May 2022
Accepted: 25 May 2022
First Online: 22 June 2022
Competing interests
: The 13-gene classifier distinguishing Kawasaki disease from other conditions has been patented by Imperial Innovations, a subsidiary of Imperial College London. The patent has been licensed to SkylineDx. R.K., D.H., D.v.K., and D.T. are employees and option holders of SkylineDx. No other disclosures were reported.
: Patients were recruited, with written parental informed consent, under approval by the research ethics committees of the United Kingdom (St Mary’s Hospital 09/H0712/58, 13/LO/0026); Spain (Ethical Committee of Clinical Investigation of Galicia [CEIC] 2010/015); Amsterdam, the Netherlands (NL41023.018.12 and NL34230.018.10); and the University of California San Diego (Human Research Protection Program 140220).